Company Filing History:
Years Active: 2019-2020
Title: Innovations of Brad W Arenz in Biofilm Treatment
Introduction
Brad W Arenz is an accomplished inventor based in Orlando, FL, with a focus on innovative solutions for biofilm treatment. He holds two patents that showcase his expertise in this critical area of research. His work is particularly significant in the medical and industrial fields, where biofilms can pose serious challenges.
Latest Patents
Arenz's latest patents include compositions and methods to prevent and treat biofilms. These patents are based on the discovery of the role of the disaccharide trehalose in microbial biofilm development. The methods he developed involve administering trehalase, the enzyme that degrades trehalose, in combination with other saccharidases. This approach is designed to adequately degrade the biofilm gel matrix at the site of the biofilm. Additionally, his methods include the use of other enzymes such as proteolytic, fibrinolytic, and lipolytic enzymes to break down proteins and lipids present in the biofilm. Antimicrobials are also administered for the specific types of infectious pathogens underlying the biofilm. Furthermore, his patents address the degradation of biofilms on medical device surfaces and in industrial settings.
Career Highlights
Throughout his career, Arenz has made significant contributions to the field of biofilm research. His innovative approaches have led to advancements in how biofilms are treated and managed. His work has implications for both healthcare and industrial applications, making it vital for improving outcomes in these areas.
Collaborations
Arenz has collaborated with notable professionals in his field, including Svetlana A Ivanova and Dennis W Davis. These collaborations have further enriched his research and development efforts.
Conclusion
Brad W Arenz is a pioneering inventor whose work in biofilm treatment is making a substantial impact. His patents reflect a deep understanding of microbial behavior and innovative methods to combat biofilm-related challenges.